A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study
- 1 November 2019
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 217, 52-63
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Bristol-Myers Squibb
This publication has 40 references indexed in Scilit:
- Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric PopulationCardiology and Therapy, 2016
- Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart PalliationThe Journal of Pediatrics, 2012
- Current and future management of pediatric venous thromboembolismAmerican Journal of Hematology, 2012
- A Multicenter, Randomized Trial Comparing Heparin/Warfarin and Acetylsalicylic Acid as Primary Thromboprophylaxis for 2 Years After the Fontan Procedure in ChildrenJACC, 2011
- Management of Warfarin in Children With Heart DiseasePediatric Cardiology, 2011
- The Fontan Patient: Inconsistencies in Medication Therapy Across Seven Pediatric Heart Network CentersPediatric Cardiology, 2010
- KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in childrenThrombosis Research, 2009
- Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliationAmerican Heart Journal, 2006
- Difficulties in performing clinical trials of antithrombotic therapy in neonates and childrenThrombosis Research, 2006
- The Pediatric Heart Network: A Primer for the Conduct of Multicenter Studies in Children with Congenital and Acquired Heart DiseasePediatric Cardiology, 2005